RE:RE:RE:RE:TLT Anti-Cancer Tech Treats 6th Patient for Bladder CancerOther than a lack of news on the 4th patient, I thought this news release was encouraging. However, with a BID/ASK of .20/.21 the market speculators/investors are figuring this is more fluff. Obviously, a few events are still hanging over TLT.